ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 41 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $248,000 | -63.6% | 37,000 | -65.4% | 0.01% | -56.2% |
| Q2 2022 | $681,000 | +37.3% | 107,000 | 0.0% | 0.02% | +60.0% |
| Q1 2022 | $496,000 | -64.8% | 107,000 | +603.9% | 0.01% | -65.5% |
| Q1 2015 | $1,408,000 | +8.1% | 15,200 | -52.8% | 0.03% | -3.3% |
| Q4 2014 | $1,302,000 | +50.0% | 32,200 | -9.3% | 0.03% | +36.4% |
| Q3 2014 | $868,000 | +113.3% | 35,500 | +38.1% | 0.02% | +100.0% |
| Q2 2014 | $407,000 | +7.7% | 25,700 | +2.8% | 0.01% | 0.0% |
| Q1 2014 | $378,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |